Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 49.30

-2.8%

Nov 20 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (2719)	1/30/2001 6:29:44 AM
From: SnowShredder	Read Replies (2) of 52153

Hi George, The data that Onyx released in Aug 2000 was impressive, but I'm a little disappointed with the results of CI-1042 as a stand alone drug. The agreement with XOMA makes me think that they have confidence in their product, but on the other hand, if this product doesn't pan out, what else do they have in the pipe? and do they have the $ to take their pipe to market? BWDIK? If you're into replicating viruses check out Oncolytics Biotech (although I haven't figured out how to buy a Canadian biotech through my broker yet >gg<). Subject 31728 Best of Luck, WHG?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next